Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

Market Cap	107.72B
Revenue (ttm)	68.18B
Net Income (ttm)	5.23B
Shares Out	97.90M
EPS (ttm)	53.46
PE Ratio	20.58
Forward PE	n/a
Dividend	10.00 (0.91%)
Ex-Dividend Date	Apr 14, 2025

Volume	6,335
Average Volume	30,975
Open	1,117.98
Previous Close	1,102.50
Day's Range	1,087.00 - 1,118.91
52-Week Range	443.01 - 1,310.00
Beta	0.56
RSI	53.56
Earnings Date	Apr 25, 2025

About PSX:ABOT

Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland. It operates through Pharmaceutical, Nutritional, Diagnostics, and Others segments. The company offers portfolio of products in various therapeutic areas, including women’s and men’s health, gastroenterology, central nervous system, pediatrics, vitamins, cardiometabolic and metabolic, pain and f...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1888
• Employees: 1,430
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: ABOT

Financial Performance

In 2024, PSX:ABOT's revenue was 68.18 billion, an increase of 22.90% compared to the previous year's 55.48 billion. Earnings were 5.23 billion, an increase of 1899.50%.